Center of Excellence: Migraine: Journal Articles

• Treating Migraine With Occipital and Trigeminal Neurostimulation Is concurrent non-invasive stimulation of occipital and trigeminal nerves safe and effective for acute treatment of migraine?
  Headache, October 19, 2022
• ECG AF Prediction Model: Migraine With vs. Without Aura Using a novel AI-enabled ECG algorithm, this study found that patients with migraine with aura have a significantly higher probability of paroxysmal or impending AF compared to those without aura.
  Headache, October 12, 2022
• Triptan Use Among Migraine Patients With Contraindications This study found that a substantial proportion of patients with migraine who have contraindications to triptans, such as cardiovascular or cerebrovascular disease, are being prescribed them anyway.
  Headache, September 16, 2022
• Patient-Identified Most Bothersome Symptom for Migraine A novel patient-centric measure that identifies the most bothersome symptoms of migraine could help inform preventive treatment decisions.
  Headache, August 15, 2022
• Ketorolac and Metoclopramide for Migraine in the ED Is this combination therapy an effective strategy for the acute treatment of pediatric migraine in the ED?
  Headache, August 08, 2022
• Mechanisms of Adolescent Migraine: Relationships With Sleep To what extent are sleep problems associated with migraines in adolescents?
  Headache, August 01, 2022
• Subsequent Dosing After Suboptimal Response With Eptinezumab Is there benefit to a second dose of eptinezumab in patients who failed to respond to the initial dose for migraine prevention?
  Headache, July 18, 2022
• Treatment of Chronic Migraine With Medication Overuse A recent trial evaluated differing strategies for treating chronic migraine and associated as-needed medication overuse.
  Headache, July 11, 2022
• Update on Migraine Management This Practice Pearl presents a brief review of recent advances in our understanding of the pathophysiology of migraine, with a focus on the development of new targeted migraine therapies.
  Menopause, July 04, 2022
• Migraine, Interferon beta-1a and Immunomodulator Therapies In this patient with multiple sclerosis, the addition of interferon beta-1a immunomodulation therapy resolved his severe migraine attacks. Might it be an effective therapy for autoimmune migraine?
  BMC Anesthesiology, June 06, 2022
• A Real-World Study of Erenumab for Migraine Prevention Does real-world evidence support the safety and efficacy of preventive erenumab therapy in patients with episodic and chronic migraine?
  Headache, June 06, 2022
• Erenumab Dosage for Migraine Prevention Erenumab is used to help prevent migraine headaches, but what is the optimal dosage?
  Headache, May 23, 2022
• Psychological Interventions for Adults With Migraine A new review examines the potential beneficial effects of psychological interventions in adults with migraine.
  Headache, May 16, 2022
• Receiving Medical Care for Chronic Migraines How can primary care providers improve care for patients with chronic migraine? This study aimed to elucidate patients' experiences and frustrations with current approaches to care.
  Southern Medical Journal, May 05, 2022
• Impact of the COVID-19 Pandemic on People Living With Migraine The results of this study revealed that the global COVID-19 pandemic resulted in both negative and positive impacts for people living with migraine.
  Headache, April 22, 2022
• The Endocannabinoid System for the Treatment of Migraine Pain Might metabolic pathways of the endocannabinoid system be a target for new migraine treatments? This review explores the possible effects of cannabis and endocannabinoids in migraine-related pain.
  Headache, April 15, 2022
• Efficacy of Galcanezumab at the End of the Treatment Cycle A new study examines the question of whether galcanezumab decreases in efficacy at the end of a treatment cycle.
  Headache, March 31, 2022
• Caffeine and Caffeine Cessation Effects in Migraine Patients Chronic caffeine use may be associated with cerebrovascular reactivity impairments among patients with migraine, but these impairments may improve after discontinuation.
  Headache, March 24, 2022
• Reducing the Impacts of Episodic Migraine Might treatment with erenumab help to mitigate the functional impacts of episodic migraine?
  Headache, March 17, 2022
• Diagnosis, Consultation, Treatment, and Impact of Migraine Findings from the OVERCOME study provide insight into the consultation, diagnosis, and treatment of migraine in the U.S.
  Headache, March 10, 2022